Scientists in Israel say they have developed the first blood test for the early detection of breast cancer. This test is called Octavia Pink and is currently available in Israel and Italy. What about here in the U.S.?
In the U.S., Octavia Pink is undergoing clinical trials in order to receive FDA approval. The test works by looking at antibodies in the blood. In addition to this test, EventusDx has developed a new technology that can process 96 blood samples at one time and takes no more than 3 hours. This technology allows a woman’s doctor to rule out or confirm a diagnosis very quickly. Researchers say the Octavia Pink test has proven to be more accurate at detecting breast cancer than mammograms. Results of the Israeli study show that the test correctly diagnosed 95% of healthy women and 75% of women with breast cancer.